Direkt zum Inhalt
Merck

SRP0310

Sigma-Aldrich

HDAC6 H216A human

recombinant, expressed in baculovirus infected Sf9 cells, ≥75% (SDS-PAGE)

Synonym(e):

HD6, JM21, histone deacetylase 6

Anmeldenzur Ansicht organisationsspezifischer und vertraglich vereinbarter Preise

Größe auswählen

50 μG
€ 488,00

€ 488,00


Versand in der Regel in 2 Wochen.

Bulk-Bestellung anfordern

Größe auswählen

Ansicht ändern
50 μG
€ 488,00

About This Item

UNSPSC-Code:
12352200
NACRES:
NA.32

€ 488,00


Versand in der Regel in 2 Wochen.

Bulk-Bestellung anfordern

Biologische Quelle

human

Rekombinant

expressed in baculovirus infected Sf9 cells

Assay

≥75% (SDS-PAGE)

Form

aqueous solution

Mol-Gew.

161 kDa

Verpackung

pkg of 50 μg

Lagerbedingungen

avoid repeated freeze/thaw cycles

Konzentration

0.65 mg/mL

NCBI-Hinterlegungsnummer

UniProt-Hinterlegungsnummer

Versandbedingung

dry ice

Lagertemp.

−70°C

Angaben zum Gen

human ... HDAC6(10013)

Allgemeine Beschreibung

HDAC6 (histone deacetylase 6) belongs to the HDAC family of proteins. HDACs are responsible for deacetylation of nuclear histone and nonhistone proteins, including transcription factors.[1] The mutation H216A results in catalytically inactive HDAC6.[2]
Human HDAC6 with H216A mutation (GenBank Accession No. NM_006044), full length with N-terminal GST tag, MW= 161kDa, expressed in a Baculovirus expression system.

Biochem./physiol. Wirkung

HDAC6 (histone deacetylase 6) is involved in the control of microtubules, growth factor-mediated chemotaxis, stress response in presence of misfolded protein and tumor invasion. It also participates in EGF (epidermal growth factor)-mediated β-catenin nuclear presence and activation of c-myc. In mouse model, HDAC6 is implicated in oncogene-induced tumorigenesis.[3] HDAC6 is the main deacetylase for α-tubulin and thus, is involved in cell motility.[4][5] It is also involved in the formation of SGs (stress granules) and SG proteins.[5] Mutations in the 3′-UTR of the HDAC6 gene suppresses hsa-miR-433-mediated post-transcriptional regulation. This results in overexpression of HDAC6, thereby causing X-linked chondrodysplasia.[6]

Lagerklassenschlüssel

12 - Non Combustible Liquids

WGK

WGK 1

Flammpunkt (°F)

Not applicable

Flammpunkt (°C)

Not applicable


Hier finden Sie alle aktuellen Versionen:

Analysenzertifikate (COA)

Lot/Batch Number

Die passende Version wird nicht angezeigt?

Wenn Sie eine bestimmte Version benötigen, können Sie anhand der Lot- oder Chargennummer nach einem spezifischen Zertifikat suchen.

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen

Jiaqi Liu et al.
Journal of translational medicine, 14, 7-7 (2016-01-10)
Histone deacetylase (HDAC) inhibitors are widely used in clinical investigation as novel drug targets. For example, panobinostat and vorinostat have been used to treat patients with melanoma. However, HDAC inhibitors are small-molecule compounds without a specific target, and their mechanism
Li S. et al.
Neurology, 41, 112-116 (2010)
Histone deacetylase 6 binds polyubiquitin through its zinc finger (PAZ domain) and copurifies with deubiquitinating enzymes.
Hook SS, et al.
Proceedings of the National Academy of Sciences of the USA, 99, 13425-13425 (2002)
Loss of a-Tubulin Acetylation Is Associated with TGF-?-induced Epithelial-Mesenchymal Transition.
Gu S, et al.
The Journal of Biological Chemistry, 291, 5396-5396 (2016)
HDAC11 is a novel drug target in carcinomas.
Deubzer HE, et al.
International Journal of Cancer. Journal International Du Cancer, 132, 2200-2200 (2013)

Questions

Reviews

No rating value

Active Filters

Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..

Setzen Sie sich mit dem technischen Dienst in Verbindung.